A Japanese Post-marketing Surveillance of Cetuximab (Erbitux®) in Patients with Metastatic Colorectal Cancer

A Japanese Post-marketing Surveillance of Cetuximab (Erbitux®) in Patients with Metastatic Colorectal Cancer

Bibliographic Details
Main Authors:	Ishiguro, Megumi, Watanabe, Toshiaki, Yamaguchi, Kensei, Satoh, Taroh, Ito, Hideyuki, Seriu, Taku, Sakata, Yuh, Sugihara, Kenichi
Format:	Online
Language:	English
Published:	Oxford University Press 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314322/

Similar Items

Severe Infusion Reactions to Cetuximab Occur within 1 h in Patients with Metastatic Colorectal Cancer: Results of a Nationwide, Multicenter, Prospective Registry Study of 2126 Patients in Japan
by: Yamaguchi, Kensei, et al.
Published: (2014)

Incidence and Clinical Features of Drug-induced Lung Injury in Patients with Advanced Colorectal Cancer Receiving Cetuximab: Results of a Prospective Multicenter Registry
by: Satoh, Taroh, et al.
Published: (2014)

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study
by: Soda, Hitoshi, et al.
Published: (2015)

Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial
by: Habl, G, et al.
Published: (2013)

Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients
by: Kurokawa, Marie, et al.
Published: (2015)

Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer
by: Yonesaka, Kimio, et al.
Published: (2015)

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
by: Watanabe, Toshiaki, et al.
Published: (2015)

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial
by: Khan, Khurum, et al.
Published: (2016)

Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
by: Harigai, Masayoshi, et al.
Published: (2016)

Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer
by: MASUDA, TAIKI, et al.
Published: (2016)

HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
by: Takegawa, Naoki, et al.
Published: (2015)

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
by: Yamaguchi, Kensei, et al.
Published: (2012)

Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
by: Yamaguchi, Kensei, et al.
Published: (2012)

Safety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution
by: SONODA, HIROMICHI, et al.
Published: (2013)

Perioperative and Long-term Outcomes of Carotid Endarterectomy for Japanese Asymptomatic Cervical Carotid Artery Stenosis: A Single Institution Study
by: ISHIGURO, Taichi, et al.
Published: (2015)

Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
by: Ishiguro, Megumi, et al.
Published: (2012)

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†
by: Boku, Narikazu, et al.
Published: (2014)

Cetuximab in the management of colorectal cancer
by: Lenz, Heinz-Josef
Published: (2007)

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
by: Koike, Takao, et al.
Published: (2011)

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
by: Sawaki, Akira, et al.
Published: (2011)

Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis
by: Kojima, Motohiro, et al.
Published: (2016)

Japanese Surveillance Systems and Treatment for Influenza
by: Zaraket, Hassan, et al.
Published: (2016)

Cetuximab in Refractory Skin Cancer Treatment
by: Kalapurakal, Sini J, et al.
Published: (2012)

Cetuximab in Refractory Skin Cancer Treatment
by: Sini J Kalapurakal, James Malone, K. Thomas Robbins, Lucinda Buescher, John Godwin, Krishna Rao
Published: (2012-01-01)

Characteristics of Perceived Stress and Salivary Levels of Secretory Immunoglobulin A and Cortisol in Japanese Women With Premenstrual Syndrome
by: Watanabe, Kaori, et al.
Published: (2015)

Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study
by: Feng, Qingyang, et al.
Published: (2016)

Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
by: Jehn, C F, et al.
Published: (2012)

A Case of Panitumumab-Responsive Metastatic Rectal Cancer Initially Refractory to Cetuximab
by: Kasagi, Yuta, et al.
Published: (2013)

Treatment of Recurrent Metastatic Head and Neck Cancer: Focus on Cetuximab
by: Patel, Akshar N., et al.
Published: (2012)

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
by: Yoshino, Takayuki, et al.
Published: (2012)

Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment
by: Aoyama, Yumiko, et al.
Published: (2012)

Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab
by: Osumi, Hiroki, et al.
Published: (2015)

Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
by: Inoue, Hiroshi, et al.
Published: (2016)

Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer
by: Takahashi, Hidenori, et al.
Published: (2015)

Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling
by: Chang, Jae Won, et al.
Published: (2015)

Impact of cetuximab conventional dosing on cetuximab-induced magnesium concentration under haemodialysis in head and neck cancer
by: Thariat, Juliette, et al.
Published: (2008)

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
by: Falivene, Sara, et al.
Published: (2014)

Japanese Physicians’ Views on Drug Post-Marketing Surveillance
by: Maeda, Kazuki, et al.
Published: (2015)

The relationship between spinal and pelvic parameters in the Japanese patients with adolescent idiopathic scoliosis
by: Ito, Kenyu, et al.
Published: (2015)

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
by: Hsu, Hung-Chih, et al.
Published: (2016)